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Chapter 7
Deacylation of the Transmembrane
Domains of Sindbis Virus Envelope
Glycoproteins E1 and E2 Does Not
Affect Low-pH-Induced Viral
Membrane Fusion Activity





The envelope glycoproteins E1 and E2 of Sindbis virus are palmitoylated at
cysteine residues within their transmembrane domains (E1 at position 430, and E2
at positions 388 and 390). Here, we investigated the in vitro membrane fusion
activity of Sindbis virus variants (derived from the Toto1101 infectious clone), in
which the E1 C430 and/or E2 C388/390 residues had been substituted for
alanines. Both the E1 and E2 mutant viruses, as well as a triple mutant virus, fused
with liposomes in a strictly low-pH-dependent manner, the fusion characteristics
being indistinguishable from those of the parent Toto1101 virus. These results
demonstrate that acylation of the transmembrane domain, of Sindbis virus E1 and
E2 is not required for expression of viral membrane fusion activity.
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Introduction
Sindbis virus (SIN), the prototype member of the genus Alphavirus of the family
Togaviridae, contains three major structural proteins: the capsid protein, C, and two
envelope glycoproteins, E2 and E2 (15, 27, 33). The E1 and E2 proteins, which
mediate the infectious host cell entry of the virus, are exposed on the viral surface
as 80 trimeric spikes each consisting of three E1/E2 heterodimers. E1 and E2 are
type-I integral membrane proteins with a single transmembrane anchor sequence
and a very small C-terminal domain located at the internal half of the viral
membrane. The transmembrane sequences of E1 and E2 contain a number of
cysteine residues, which are conserved among most of the members of the
alphavirus genus and represent potential sites for covalent attachment of long-
chain fatty acids. Indeed, in SIN, these cysteine residues, at E1 position 430 and
E2 positions 388 and 390, appear to be palmitoylated (26).
Not only the spike proteins of alphaviruses, but in fact many transmembrane
glycoproteins of animal viruses have been shown to be acylated (11, 28, 31). These
include the G protein of vesicular stomatitis virus (37), the hemagglutinin (HA) of
influenza virus (19, 20, 29, 32, 34) and the transmembrane subunit of the envelope
glycoproteins of human and simian immunodeficiency viruses (39). Although
modification with long-chain fatty acids thus appears to be a common
phenomenon among viral transmembrane proteins, the biological function of this
acylation remains elusive. Several investigators have used site-directed mutagenesis
in order to selectively replace the cysteine residues that provide sites for acylation.
Such modified proteins have been studied after expression in cultured cells or in
systems generating recombinant viruses. However, conflicting results have been
obtained with regard to the role that spike protein acylation plays in the life cycle
of the viruses involved. Particularly, the potential function of fatty acids in the
membrane fusion activity of viral spikes, such as the influenza virus hemagglutinin,
has remained controversial (7, 14, 17, 19, 24, 29, 32, 40).
With regard to SIN, studies involving site-specific mutagenesis have
demonstrated that deacylation of the transmembrane domains of the E1 and/or
E2 spike glycoproteins slows down virus growth early in infection (26).
Furthermore, these deacylation mutant viruses are more sensitive to treatment
with detergent as compared to wild-type SIN (26). Little is known about the
potential effect of spike protein deacylation on the membrane fusion activity of
SIN. However, the fact that the E1 and/or E2 deacylation SIN mutants do infect
a variety of cell types (26) suggests that the viral life cycle, including the membrane
fusion step, is unlikely to be grossly affected by lipid modification.
Here, we studied the effect of deacylation of the transmembrane domains of
SIN glycoproteins E1 and E2 on the viral membrane fusion capacity. Fusion of
SIN virus derived from the infections clone Toto1101 and several acylation
mutants was evaluated in a liposomal model system on the basis of both lipid
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mixing and contents mixing. It is demonstrated that SIN fuses rapidly and
efficiently with liposomes in a strictly low-pH-dependent manner. Moreover,
deacylation of the transmembrane domains of E1 and/or E2 had no effect on the
membrane fusion characteristics of the virus.
Materials and Methods
Acylation mutant SIN viruses. A cDNA, containing the Toto1101 infectious clone
of SIN virus (25), as well as three acylation mutant cDNAs, were generously provided by
Dr. Milton Schlesinger (Washington University, St. Louis, MO, USA). In the first
acylation mutant, the transmembranal cysteine at E1 position 430 had been substituted
for an alanine (E1:C430A), which results in an almost complete lack of palmitoylation of
E1 and a minor reduction in palmitoylation of E2 (26). In the second mutant, the
cysteines at E2 positions 388 and 390 had been substituted for alanines (E2:C388A-
C390A), resulting in a reduction of E2 palmitoylation by about 70% and a reduction in E1
palmitoylation by about 50% (26). The third mutant, with all three transmembrane
cysteine mutations in E1 and E2 (E1:C430A/E2:C388A-C390A), lacks E1 palmitoylation
completely and has a residual 30% palmitoylation of E2 (26). The residual fatty acid
binding to E2 in the presence of the C388A and C390A mutations is presumably due to
acylation at other cysteine residues in the cytoplasmic domain of the protein (12).
Production and characterization of virus particles. For the production of virus
particles, RNA was synthesized and transfected into baby hamster kidney cells (BHK-21)
by electroporation, as described previously (16). Viruses released from cells at 20 h post-
transfection were harvested, and these stocks were subsequently used directly for the
production of pyrene- and [35S]methionine-labeled viruses, essentially as described before
for Semliki Forest Virus (SFV) or SIN (2, 21, 30). The concentration of the virus
preparations was determined by lipid phosphate (1) and protein (23) analysis. The purity
of the virus particles was confirmed by SDS-PAGE. Viral infectivity was determined by
titration on BHK-21 cells in 96-well plates.
Preparation of liposomes. Liposomes (large unilamellar vesicles) were prepared in 5
mM Hepes, 150 mM NaCl, 0.1 mM EDTA, pH 7.4 (HNE) by subjection of lipid
mixtures, dried from chloroform solution, to five cycles of freezing and thawing and
subsequent extrusion (10) through 0.2 µM filters (Nuclepore Inc., Pleasanton, CA, USA)
in a LiposoFast mini-extruder (Avestin, Ottawa, Canada). Liposomes consisted of
phospholipids (Avanti Polar Lipids, Alabaster, AL, USA) and cholesterol (Sigma Chem.
Co., St Louis, MO, USA). The phospholipids were phosphatidylcholine (PC) derived from
egg yolk, phosphatidylethanolamine (PE) prepared by transphosphatidylation of egg-PC,
and sphingomyelin (SPM) from egg yolk, mixed with cholesterol (Chol) in a molar ratio of
1:1:1:1.5.  Trypsin-containing liposomes were prepared likewise, only in this case lipids
were dispersed in HNE containing 10 mg/ml trypsin (Fluka Chemie Ag, Buchs,
Switzerland). The trypsin-containing liposomes were separated from free trypsin by gel
filtration on a Sephadex G-100 column in HNE. The phospholipid concentration of the
liposome preparations was determined by phosphate analysis (1).
Fusion assays. Fusion of pyrene-labeled SIN with liposomes was monitored on-line
in an AB2 fluorimeter (SLM/Aminco, Urbana, IL), as described previously (30). Briefly,
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pyrene-labeled SIN (0.5 µM viral phospholipid) and liposomes (200 µM phospholipid)
were mixed in a volume of 0.665 ml in HNE, in a quartz cuvette, magnetically stirred and
maintained at 37 °C. At t=0 s, fusion was initiated by the addition of 0.035 ml 0.1 M
MES, 0.2 M acetic acid, pretitrated with NaOH to achieve the final desired pH. The
fusion scale was calibrated such that the initial pyrene excimer fluorescence at 480 nm
represented 0% fusion. The 100 % fusion value was set after addition of 0.035 ml 0.2 M
octaethyleneglycol monododecyl ether (Fluka Chemie AG). The initial rate of fusion was
determined from the tangent to the first part of the curve. The extent of fusion was
determined 60 s after acidification.
Fusion of SIN with liposomes was also assessed using a contents mixing assay based
on degradation of the viral capsid protein by trypsin, initially encapsulated in the
liposomes (18, 30, 36). Briefly, [35S]methionine-labeled virus (0.5 µM phospholipid) was
incubated with trypsin-containing PC/PE/SPM/Chol liposomes (200 µM liposomal
phospholipid) in presence of 125 µg/ml trypsin inhibitor (Boehringer, Mannheim,
Germany) in the external medium, at 37 °C. The mixture was acidified, under continuous
stirring, to the desired pH with 0.1 M MES, 0.2 M acetic acid, as described above. After
30 s, samples were neutralized by the addition of a pretitrated volume of 0.1 M NaOH,
and further incubated for 1 h at 37 °C. Subsequently, samples were analyzed by SDS-
PAGE, the protein bands being visualized by autoradiography. Quantification of the viral
proteins was done by phosphorimaging analysis using Image Quant 3.3 software
(Molecular Dynamics, Sunnyvale, CA, USA).
Results
Low-pH-dependent fusion of pyrene-labeled SIN with liposomes. Fusion
of SIN was measured on-line in a liposomal model system, using a lipid mixing
assay based on pyrene excimer fluorescence (2, 21, 30). In order to exclude any
potential effects of the fluorescence labeling procedure on the biological
properties of the virus, we first evaluated the specific infectivities of pyrene-labeled
Toto1101 and acylation mutant SIN virus preparations. Viral infectivity was
determined by titration on BHK-21 cells and related to the number of virus
particles present based on biochemical analyses (30). In all cases a particle to
infectious unit ratio of 4-5 was found, similar to that seen in unlabeled virus (data
not shown). These results demonstrate that neither the fluorescence labeling
procedure nor the presence of the acylation mutations in E1 and/or E2 had any
significant effect on the specific infectivity of the viruses.
The pyrene fusion assay relies on a decrease of pyrene excimer fluorescence
owing to dilution of pyrene-labeled phospholipids from the viral into the
liposomal membrane. This decrease can be translated directly to the extent of
fusion, since each individual fusion event results in a large dilution of the probe
and, thus, in an essentially complete disappearance of the excimer fluorescence
intensity of the virus particle involved. Figure 1 presents the fusion kinetics of
pyrene-labeled Toto1101 SIN virus with PC/PE/SPM/Chol liposomes. At pH
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4.6, the virus fused rapidly and efficiently with the liposomes, the extent of fusion
being approximately 55% at 10 s after acidification of the virus-liposome mixture
(curve a). With increasing pH, fusion became slower and less extensive (curves b,
c). At pH 7.4 there was no detectable fusion (curve d). We also measured fusion of
pyrene-labeled Toto1101 SIN virus with liposomes lacking either SPM or Chol or
both, and observed that fusion was absent (data not shown). These results indicate
that the membrane fusion activity of SIN derived from the Toto1101 infectious
clone is triggered by a mildly acidic pH and exhibits a similar overall lipid
dependence as fusion of wild-type SIN (laboratory-adapted strain AR339) (30) or
SFV (4, 21).
Figure 1. Low-pH dependent fusion of pyrene-labeled SIN derived from cDNA clone
Toto1101 with liposomes. Fusion of pyrene-labeled SIN Toto1101 with PC/PE/SPM/Chol
liposomes was measured on-line at 37 °C as described in Materials and Methods. Final
concentrations of virus and liposomes corresponded to 0.5 µM and 200 µM phospholipid,
respectively. Curves: a, pH 4.6; b, pH 5.0; c, pH 5.75; d, pH 7.4.
Fusion characteristics of SIN acylation mutants. Figure 2 presents the
fusion kinetics of the three acylation mutant SIN viruses, E1:C430A, E2:
388A/C390A, and E1:C430A/E2:C388-C390A, in comparison with the original
Toto1101 virus. Clearly, the fusion kinetics of the acylation mutants were
indistinguishable from those of the unmodified virus. Importantly, none of the
viruses had any significant fusion activity at neutral pH.
Figure 3 compares the detailed pH dependence of Toto1101 (open triangles)
and the acylation mutant virus E1:C430A/E2:C388A-C390A (closed triangles).
Panel A shows the initial rate of fusion as a function of the pH, determined from
the tangent to the first part of the fusion curves. Rates were very similar for
unmodified and acylation mutant viruses in the entire pH range from pH 4.0 to
pH 7.4. Figure 3B presents the extent of fusion as function of the pH, measured
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differences were observed between the unmodified and acylation mutant SIN.
Under optimal conditions, 18-20% of the virus particles fused within the first
second after acidification, with an extent of fusion of 60% at 60 s post-
acidification. The pH threshold for fusion was 6.2 for both viruses. The acylation
mutant viruses E1:C430A and E2:C388A-C390A gave essentially identical results
in terms of initial rate and extent of fusion (data not shown).
Figure 2. Low-pH dependent fusion of pyrene-labeled acylation mutant SIN viruses
with liposomes. Fusion of pyrene-labeled acylation mutant viruses with liposomes was
measured at pH 4.6 and 7.4, as described in the legend to Figure 1. Curves: a, SIN; b,
E1:C430A; c, E2:C388A/C390A; d, E1:C430A/E2:C388A/C390A .
Figure 3. Comparison of the pH-dependent of fusion of pyrene-labeled acylation
mutant and SIN Toto1101 viruses. Fusion of SIN Toto1101 (open triangles) and the
acylation mutant virus, E1:C430A/E2:C388A/C390A (closed triangles) was determined at
different pH values, as described in the legend to Figure 1. (A) The initial rates of fusion were
determined from the tangent to the first part of the curve.  (B) The extents of fusion were

















































Contents mixing of [35S]methionine-labeled SIN with trypsin-containing
liposomes. In the above experiments fusion was evaluated on the basis of lipid
mixing. Another, very stringent, criterion for fusion involves the coalescence of
the interior of the virus with the liposomal lumen. Contents mixing was assayed as
the degradation of the viral capsid protein by trypsin, initially encapsulated in the
liposomes. Figure 4A shows the capsid degradation of SIN Toto1101 and the
acylation mutant virus E1:C430A/E2:C388A-C390A. In both cases,
incubation of the virus with trypsin-containing liposomes at pH 4.6 resulted in the
Figure 4. Degradation of the viral capsid protein by trypsin, initially incorporated in
liposomes. The trypsin assay was carried out as described in the Materials and Methods. Final
concentrations of [35S]methionine-labeled virus and (trypsin-containing) PC/PE/SPM/Chol
liposomes corresponded to 0.5 µM and 200 µM phospholipid, respectively. (A) Viral structural
proteins of SIN Toto1101 (lanes a-c) and acylation mutant E1:C430A/E2:C388A/C390A (lane
d-f), visualized by autoradiography. Lanes: a and d, trypsin-containing liposomes at pH 4.6; b
and e, trypsin-containing liposomes at pH 7.4; c and f, empty liposomes at pH 4.6. (B)
Quantification of the extent of capsid protein degradation on the basis of the ratio
C/[C+E1+E2] by phosphorimaging analysis. The ratios C/[C+E1+E2] of the controls, in
which empty liposomes were incubated with the viruses under otherwise identical conditions,
were taken as the 100% values. Bars: shaded, SIN; open, E1:C430A/E2:C388A/C390A.
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degradation of a substantial fraction of the capsid protein (lane a, d).  At pH 7.4 no
capsid degradation was observed (lane b, e). The controls, in which the viruses
were incubated with empty liposomes at pH 4.6, did not show degradation of the
capsid protein either (lane c, f). The ratio of the radioactivity of the capsid band
relative to the total radioactivity (C+E1/E2) of the samples incubated at pH 7.4
and the control samples with empty liposomes was close to 0.4, as expected on the
basis of the number of methionine residues in the SIN structural proteins (33).
Complete degradation of the capsid protein was observed when Triton X-100 was
added to the reaction mixture, in the absence of trypsin inhibitor (results not
shown). Figure 4B shows the extent of capsid degradation as function of the pH,
quantified by phosphorimaging. For SIN Toto1101, incubated at pH 4.6,
approximately 70% of the capsid protein was degraded, while at pH 5.0 and pH
5.5 the corresponding numbers were 41% and 19%, respectively. With the triple
acylation mutant virus, E1:C430A/E2:C388A-C390A, we detected an extent of
capsid degradation of 72% at pH 4.6, 45% at pH 5.0, and 25% at pH 5.5. Similar
results were obtained with the separate E1 or E2 acylation mutant viruses (results
not shown). The extents of capsid protein degradation seen in the pH range from
4.6 to 5.5 (Figure 4B) are very similar to the corresponding extents of lipid mixing
observed in the pyrene fluorescence assay (Figure 3B).
Discussion
The results presented in this paper demonstrate that SIN derived from the
infectious clone Toto1101 fuses rapidly and efficiently with receptor-free
cholesterol- and sphingolipid-containing liposomes in a strictly low-pH-dependent
manner. Fusion was evaluated on the basis of both membrane lipid mixing and
internal contents mixing between the virus and the liposomes. The pH
dependence of fusion of the Toto1101 virus is very similar to that of the wild-type,
laboratory-adapted, SIN strain AR339 (30) and argues strongly for a cell entry
mechanism of SIN involving receptor-mediated endocytosis and acid-induced
fusion of the viral envelope with the endosomal membrane. This is entirely
consistent with recent observations of Glomb-Reinmund and Kielian (8). These
investigators showed that infection of BHK-21 cells by SIN is inhibited by agents
that interfere with endosomal acidification, such as NH4Cl, balifomycin or
concanamycin. Further support for a cell entry mechanism of SIN involving
receptor-mediated endocytosis has been provided by DeTulleo and Kirchhausen
(5), who observed that BHK-21 cell infection by SIN is affected by a mutated
form of dynamin which inhibits the budding of clathrin-coated vesicles.
In the light of this fairly convincing evidence, it is intriguing that quite recently
(9) Brown  and  coworkers  have presented data which support their previous
suggestion (3, 6) that exposure to an acidic pH may not be an obligatory step in
the infection of cells by alphaviruses. These investigators observed that the
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infection of mosquito cells by SIN was not blocked by choloroquine under
conditions such that the drug did raise the pH of the endosomal compartment of
the cells (9). Although it is possible that alphaviruses use different routes of
infection in vertebrate and insect cells, our previous (2, 21, 30, 35) and present
studies in model systems, designed to specifically address the issue of alphavirus
fusion activation, strongly argue for exposure to a mildly acidic pH being an
essential step in the triggering of the fusion process.
The principal result of this study demonstrates that acylation of the
transmembrane domains of the SIN glycoproteins E1 and E2 is not required for
expression of viral membrane fusion activity. Indeed, deacylation of E1 and/or E2
has no effect on the kinetics or the detailed pH dependence of the fusion process.
This conclusion is in agreement with similar results obtained for other enveloped
viruses, such as vesicular stomatitis virus (37) and human and simian
immunodeficiency viruses (39). The potential role of acylation in the membrane
fusion activity of influenza HA however, remains controversial. HA-mediated
fusion has been studied extensively in cultured cells expressing the isolated HA,
with erythrocytes or erythrocyte ghosts serving as target membranes. In such
systems, deacylation of HA does not affect membrane lipid mixing, as measured
by fluorescence dequenching of the fluorophore R18 (7, 24). Likewise, deacylation
has been observed to have little effect on syncytia formation mediated by HA
expressed on the cell surface (32, 34). By contrast, other investigators have
reported distinct effects of deacylation of HA on various stages of the fusion
process, including initial fusion pore flickering (17) and late fusion pore dilation as
assessed by syncytia formation (7, 19). It is possible that this apparent discrepancy
is, at least in part, a consequence of the fusion process being primarily studied in
HA-expressing cells rather than with virus. In these cell systems the surface density
of HA may vary considerably and also its biological activity may be affected when
it is expressed in the absence of the M2 protein (22). It is a major advantage of our
present study that it involves the use of whole virus derived from a cDNA clone,
rather than SIN envelope glycoproteins expressed on the surface of cultured cells.
Similar approaches followed for influenza, involving reverse genetics and the
generation of mutant virions however, have again resulted in conflicting
conclusions. Zurcher et al. (40) reported that deacylation of HA affects virus
assembly, whereas little effect on either assembly or infectivity was observed by
others (13, 14, 38).
With regard to alphaviruses, SIN in particular, the lack of effect of E1 and/or
E2 deacylation on viral membrane fusion activity, reported here, and the limited
effects on virus assembly and release (28) explain the observation made by us in
the present study and by others before (28) that deacylation mutant viruses are
fully infectious on cultured cells, exhibiting specific infectivity values. On the other
hand, the conserved nature of the cysteine residues in the transmembrane domains
of the E1 and E2 envelope glycoproteins suggests that fatty acid modification of
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these proteins has an important function in the life cycle of alphaviruses. Our
present results suggest that this biological function is not at the level of the low-
pH-induced virus membrane fusion process.
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